MedTrace
Phase 3MedTrace is developing a solution that will help healthcare providers diagnose patients more accurately and quickly.
Founded
2018
Focus
DiagnosticsCardiovascular
About
MedTrace is developing a solution that will help healthcare providers diagnose patients more accurately and quickly.
Funding History
2Total raised: $12.5M
Series A$10MNovo HoldingsSep 15, 2022
Seed$2.5MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationCopenhagen, Denmark
StagePhase 3
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile